News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
443,128 Results
Type
Article (27684)
Company Profile (140)
Press Release (415304)
Section
Business (133103)
Career Advice (586)
Deals (22486)
Drug Delivery (72)
Drug Development (58043)
Employer Resources (56)
FDA (9494)
Job Trends (8385)
News (226759)
Policy (20299)
Tag
Academia (942)
Alliances (35951)
Alzheimer's disease (613)
Approvals (9465)
Artificial intelligence (91)
Bankruptcy (189)
Best Places to Work (6187)
Biotechnology (68)
Breast cancer (85)
Cancer (735)
Cardiovascular disease (65)
Career advice (510)
Cell therapy (143)
Clinical research (46956)
Collaboration (271)
Compensation (117)
COVID-19 (2089)
C-suite (73)
Data (789)
Diabetes (88)
Diagnostics (2781)
Drug pricing (61)
Earnings (44569)
Events (71151)
Executive appointments (237)
FDA (9827)
Funding (231)
Gene therapy (113)
GLP-1 (361)
Government (2212)
Healthcare (7050)
Infectious disease (2136)
Inflammatory bowel disease (65)
Interviews (84)
IPO (8779)
Job creations (2543)
Job search strategy (463)
Layoffs (219)
Legal (4871)
Lung cancer (104)
Manufacturing (129)
Medical device (3629)
Medtech (3631)
Mergers & acquisitions (13821)
Metabolic disorders (246)
Neuroscience (791)
NextGen Class of 2024 (2639)
Non-profit (1087)
Northern California (951)
Obesity (134)
Opinion (165)
Patents (67)
People (45147)
Pharmaceutical (70)
Phase I (14106)
Phase II (20739)
Phase III (15859)
Pipeline (364)
Postmarket research (1875)
Preclinical (5488)
Radiopharmaceuticals (151)
Rare diseases (146)
Real estate (3691)
Regulatory (14030)
Research institute (1034)
Resumes & cover letters (72)
Southern California (809)
Startups (2788)
United States (8081)
Vaccines (379)
Weight loss (91)
Date
Today (59)
Last 7 days (477)
Last 30 days (2618)
Last 365 days (21559)
2024 (19839)
2023 (22851)
2022 (30997)
2021 (33962)
2020 (31006)
2019 (21290)
2018 (16452)
2017 (22400)
2016 (23882)
2015 (28845)
2014 (22988)
2013 (19764)
2012 (20687)
2011 (20651)
2010 (18765)
Location
Africa (485)
Arizona (92)
Asia (29836)
Australia (4309)
California (2052)
Canada (926)
China (165)
Colorado (101)
Connecticut (93)
Europe (64912)
Florida (248)
Georgia (61)
Illinois (221)
Indiana (107)
Kansas (66)
Maryland (283)
Massachusetts (1667)
Minnesota (110)
New Jersey (670)
New York (580)
North Carolina (452)
Northern California (951)
Ohio (63)
Pennsylvania (465)
South America (795)
Southern California (809)
Texas (319)
Virginia (60)
Washington State (207)
443,128 Results for "modra pharmaceuticals b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life Sciences, B.V. to Nordic Group, B.V., a subsidiary of SEVER Life Sciences B.V., which occurred on June 1, 2023.
March 4, 2024
·
3 min read
Policy
Modra Pharmaceuticals Announces U.S. Patent Issuance for ModraDoc006/r
Modra Pharmaceuticals announced that the U.S. Patent and Trademark Office has issued to Modra U.S. Patent No. 11,571,408, covering the use of its oral taxane therapeutic ModraDoc006/r. ModraDoc006/r is an oral tablet formulation of docetaxel co-administered with ritonavir, a boosting agent that enhances bioavailability.
March 16, 2023
·
2 min read
Press Releases
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study
--Six sites across the U.S. are now engaged in Phase1b study
November 19, 2024
·
5 min read
Press Releases
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2
November 14, 2024
·
7 min read
Press Releases
Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024
October 28, 2024
·
9 min read
Pharm Country
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye.
Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., has launched LACRIFILL Canalicular Gel, a novel therapy for dry eye in the U.S. LACRIFILL Canalicular Gel is a cross-linked hyaluronic acid derivative and is FDA-cleared to temporarily block tear drainage by the occlusion of the canalicular system.
May 29, 2024
·
3 min read
Business
Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”) today announced that it will report its First Quarter 2024 Earnings Results on Wednesday, April 24, 2024, after the Mexican Stock Exchange (BMV) close.
April 4, 2024
·
2 min read
Deals
Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Clade Therapeutics today announced that it has completed the acquisition of Gadeta B.V.
October 2, 2023
·
4 min read
Business
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.
Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. Nordic Pharma recently expanded its pharmaceutical expertise in the U.S. by acquiring Visant Medical, Inc., a leader in medical technology innovation in Dry Eye Disease.
January 15, 2024
·
6 min read
Deals
Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States
Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today the completion of its acquisition of Visant Medical, Inc. (Visant), a leader in medical technology innovation in Dry Eye Disease (DED).
December 18, 2023
·
5 min read
1 of 44,313
Next
